Obesity and risk of bladder cancer: A dose-response meta-analysis of 15 cohort studies

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Sun, Jiang Wei ^a,b   Zhao, Long Gang ^a,b   Yang, Yang ^a,b   Ma, Xiao ^a,b   Wang, Ying Ying ^a,b   Xiang, Yong Bing ^a,b  

^a Shanghai Institute of Digestive Disease   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; BODY MASS; BODY WEIGHT; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; HUMAN; META ANALYSIS (TOPIC); OBESITY; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW (TOPIC); ADULT; FEMALE; MALE; META ANALYSIS; RISK FACTOR; URINARY BLADDER NEOPLASMS;

ADULT; BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; MALE; OBESITY; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84925625550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119313     Document Type: Article

References (49)

1. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C. Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol. 2006; 3: 327-340. PMID: 16763645
2. Vainio H, Bianchini F. Weight control and physical activity. IARC. 2002.
3. Smith M, Zhou M, Whitlock G, Yang G, Offer A, Hui G, et al. Esophageal cancer and body mass index: Results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer. 2008; 122: 1604-1610. PMID: 18059032
4. Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, Navarro RD, et al. Body mass index, abdominal fatness and pancreatic cancer risk: A systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol. 2012; 23: 843-852. doi: 10.1093/annonc/mdr398 PMID: 21890910
5. Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, Haboubi N, et al. Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis. 2009; 11: 547-563. doi: 10.1111/j.1463-1318.2009.01766.x PMID: 19207714
6. Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis. Int J Biol Markers. 2014; 29: e21-e29. doi: 10.5301/ jbm.5000047 PMID: 24170556
7. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010; 19: 3119-3130. doi: 10.1158/1055-9965.EPI-10-0832 PMID: 21030602
8. Wang F, Xu Y. Body mass index and risk of renal cell cancer: A dose-response meta-analysis of published cohort studies. Int J Cancer. 2014; 135: 1673-1686. doi: 10.1002/ijc.28813 PMID: 24615287
9. Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: A systematic review and dose-response metaanalysis. Obes Rev. 2013; 14: 665-678. doi: 10.1111/obr.12028 PMID: 23615120
10. Larsson SC, Andersson SO, Johansson JE, Wolk A. Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer. 2008; 44: 2655-2660. doi: 10.1016/j.ejca. 2008.07.012 PMID: 18707871
11. Koebnick C, Michaud D, Moore SC, Park Y, Hollenbeck A, Ballard-Barbash R, et al. Body mass index, physical activity, and bladder cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1214-1221. doi: 10.1158/1055-9965.EPI-08-0026 PMID: 18483344
12. Holick CN, Giovannucci EL, Stampfer MJ, Michaud DS. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer. 2007; 120: 140-146. PMID: 17036323
13. Tripathi A, Folsom AR, Anderson KE. Risk factors for urinary bladder carcinoma in postmenopausal women: The Iowa Women's Health Study. Cancer. 2002; 95: 2316-2323. PMID: 12436437
14. Nagano J, Kono S, Preston DL, Moriwaki H, Sharp GB, Koyama K, et al. Bladder-cancer incidence in relation to vegetable and fruit consumption: A prospective study of atomic-bomb survivors. Int J Cancer. 2000; 86: 132-138. PMID: 10728607
15. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JJ. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control. 2004; 15: 35-43. PMID: 14970733
16. Haggstrom C, Stocks T, Rapp K, Bjorge T, Lindkvist B, Concin H, et al. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). Int J Cancer. 2011; 128: 1890-1898. doi: 10.1002/ijc.25521 PMID: 20568111
17. Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, Concin H, et al. Obesity and incidence of cancer: A large cohort study of over 145000 adults in Austria. Br J Cancer. 2005; 93: 1062-1067. PMID: 16234822
18. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007; 335: 1134. PMID: 17986716
19. Samanic C, Chow W, Gridley G, Jarvholm B, Fraumeni JF. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Cause Control. 2006; 17: 901-909. PMID: 16841257
20. Jee SH, Yun JE, Park EJ, Cho ER, Park IS, Sull JW, et al. Body mass index and cancer risk in Korean men and women. Int J Cancer. 2008; 123: 1892-1896. doi: 10.1002/ijc.23719 PMID: 18651571
21. Andreotti G, Hou L, Beane FL, Mahajan R, Koutros S, Coble J, et al. Body mass index, agricultural pesticide use, and cancer incidence in the Agricultural Health Study cohort. Cancer Causes Control. 2010; 21: 1759-1775. doi: 10.1007/s10552-010-9603-9 PMID: 20730623
22. Cantwell MM, Lacey JV, Schairer C, Schatzkin A, Michaud DS. Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study. Int J Cancer. 2006; 119: 2398-2401. PMID: 16894568
23. Song X, Pukkala E, Dyba T, Tuomilehto J, Moltchanov V, Männistö S, et al. Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol. 2014; 29: 477-487. doi: 10.1007/s10654-014-9934-z PMID: 24997743
24. Bhaskaran K, Douglas I, Forbes H, Dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: A population-based cohort study of 5.24 million UK adults. Lancet. 2014; 384: 755-765. doi: 10.1016/S0140-6736(14)60892-8 PMID: 25129328
25. Qin Q, Xu X, Wang X, Zheng X. Obesity and risk of bladder cancer: A meta-analysis of cohort studies. Asian Pac J Cancer Pre. 2013; 14: 3117-3121. PMID: 23803089
26. Obesity: preventing and managing the global epidemic. World Health Organization. 2000. PMID: 11234459
27. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: An update. Contemp Clin Trials. 2007; 28: 105-114. PMID: 16807131
28. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21: 1539-1558. PMID: 12111919
29. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634. PMID: 9310563
30. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50: 1088-1101. PMID: 7786990
31. Il Yasova D, Hertz-Picciotto I, Peters U, Berlin JA, Poole C. Choice of exposure scores for categorical regression in meta-analysis: A case study of a common problem. Cancer Causes Control. 2005; 16: 383-388. PMID: 15953980
32. Liu Q, Cook NR, Bergström A, Hsieh C. A two-stage hierarchical regression model for meta-analysis of epidemiologic nonlinear dose-response data. Comput Stat Data Anal. 2009; 53: 4157-4167.
33. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear doseresponse relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012; 175: 66-73. doi: 10.1093/aje/kwr265 PMID: 22135359
34. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stat J. 2006; 6: 40-57.
35. Desquilbet L, Mariotti F. Dose? response analyses using restricted cubic spline functions in public health research. Stat Med. 2010; 29: 1037-1057. doi: 10.1002/sim.3841 PMID: 20087875
36. Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med. 2010; 29: 1282-1297. doi: 10.1002/sim.3602 PMID: 19408255
37. Heikkila K, Nyberg ST, Theorell T, Fransson EI, Alfredsson L, Bjorner JB, et al. Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116,000 European men and women. BMJ. 2013; 346: f165. doi: 10.1136/bmj.f165 PMID: 23393080
38. Bachir BG, Kassouf W. Cause-effect? Understanding the risk factors associated with bladder cancer. Expert Rev Anticancer Ther. 2012; 12: 1499-1502. doi: 10.1586/era.12.140 PMID: 23253215
39. Albanes D, Jones DY, Micozzi MS, Mattson ME. Associations between smoking and body weight in the US population: Analysis of NHANES II. Am J Public Health. 1987; 77: 439-444. PMID: 3493709
40. Gordon T, Kannel WB, Dawber TR, McGee D. Changes associated with quitting cigarette smoking: the Framingham Study. Am Heart J. 1975; 90: 322-328. PMID: 1163424
41. Kuskowska-Wolk A, Karlsson P, Stolt M, Rossner S. The predictive validity of body mass index based on self-reported weight and height. Int J Obes. 1989; 13: 441-453. PMID: 2793299
42. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990; 1: 466-473. PMID: 2090285
43. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol. 2002; 3: 565-574.PMID: 12217794
44. Iwamura M, Ishibe M, Sluss PM, Cockett AT. Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines. Urol Res. 1993; 21: 27-32. PMID: 8456535
45. Zhao H, Grossman HB, Spitz MR, Lerner SP, Zhang K, Wu X. Plasma levels of insulin-like growth fac-tor-1 and binding protein-3, and their association with bladder cancer risk. J Urol. 2003; 169: 714-717. PMID: 12544349
46. Probst-Hensch NM, Wang H, Goh VHH, Seow A, Lee H, Yu MC. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Pre. 2003; 12: 739. PMID: 12917205
47. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4: 579-591. PMID: 15286738
48. Hilmy M, Bartlett JMS, Underwood MA, McMillan DC. The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer. 2005; 92: 625-627. PMID: 15726119
49. Andrews B, Shariat SF, Kim JH, Wheeler TM, Slawin KM, Lerner SP. Preoperative plasma levels of in-terleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer. J Urol. 2002; 167: 1475-1481. PMID: 11832773